Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC
Clinical trial NCT05163249 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05163249
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2024-04-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.